Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Finding savings in your budget can free up more funds. Learn where to look for potential savings and enhance your budget.
18,157 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Top AI chiefs urged Congress to curb risks as AI tech makes it easier to design dangerous biological materials. The l...
Nvidia is betting on a future where it sells complete AI production lines, not just chips. This shift could redefine ...
Megapari unveils World Cup Pass 2026, offering three pass levels, free bets for task completion, and an automatic gra...
The May inflation report released this morning jolted trading desks and left investors weighing the Federal Reserve’s...
Sellers turning to private listings may avoid public exposure, but new data suggests this approach can lead to lower ...
JPMorgan Chase has set a bold 7% net interest income growth goal for 2026. This article explains why the target could...
At the SuperAI Summit in Singapore, Yat Siu laid out a firms-wide thesis that Asia will merge AI and blockchain faste...
A global survey of 6,000 professionals across 25 countries finds accounting may look completely different by 2040, dr...
Imagine a beloved sneaker brand reinventing itself with AI and a bold rebrand. This speculative piece explores how su...
In mid-June, hawkish central bank signals set the tone for global markets. The FTSE 100 faltered while the Nikkei 225...
Investors chase international dividend income, but IDV's 6-7% yield sits beside volatile cycles in oil, banks, and mi...